Prospect: information for the user
Ezetimiba/Simvastatina Pharma Combix 10 mg/40 mg tablets EFG
Read this prospect carefully before starting to take this medicine, because it contains important information for you.
Content of theprospect
Content of the package and additional information
This medicationcontains the active ingredients ezetimibe and simvastatin.It is used to reduce total cholesterol, "bad" cholesterol (low-density lipoprotein, LDL) and certain types of fat called triglycerides that circulate in the blood. Additionally, it increases the levels of "good" cholesterol (high-density lipoprotein, HDL).
Ezetimibe/simvastatinacts by reducing cholesterol in two ways. The active ingredient ezetimibe reduces the cholesterol absorbed in the digestive tract. The active ingredient simvastatin, which belongs to the group of "statins," inhibits the production of cholesterol produced by the body itself.
Cholesterol is one of the fatty substances found in the bloodstream. Its total cholesterol is composed mainly of LDL and HDL.
LDL cholesterol is often referred to as "bad" cholesterol because it can accumulate in the walls of your arteries, forming plaques. Over time, this accumulation of plaque can cause a narrowing of the arteries. This narrowing can slow down or interrupt blood flow to vital organs such as the heart and brain. This interruption of blood flow can cause a heart attack or stroke.
HDL cholesterol is often referred to as "good" cholesterol because it helps prevent bad cholesterol from accumulating in the arteries and protects them from cardiovascular diseases.
Triglycerides are another type of fat in your blood that can increase the risk of heart disease.
Ezetimibe/simvastatinis used in patients who cannot control their cholesterol levels solely with diet. While taking this medication, you must follow a cholesterol-lowering diet.
Ezetimibe/simvastatinis used, along with a cholesterol-lowering diet,if you have:
This medicationdoes not help you lose weight.
Do not take Ezetimiba/Simvastatina Pharma Combix if:
Do not take more than 10/40 mg of ezetimiba/simvastatina if you are taking lomitapida (used to treat rare and severe cholesterol disorders)
Consult your doctor if you are unsure if your medication is mentioned above.
Warnings and precautions
Inform your doctor:
Your doctor will perform a blood test before you start taking ezetimiba/simvastatina and also if you have any symptoms of liver problems while taking ezetimiba/simvastatina. This is to check how well your liver is working.
Your doctor may also want to perform blood tests to check how well your liver is working after you start taking ezetimiba/simvastatina.
While you are taking this medication, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in your blood, are overweight and have high blood pressure.
Talk to your doctor if you have a severe lung disease.
Avoid the combined use of ezetimiba/simvastatina and fibrates (certain cholesterol-lowering medications), as the combined use of ezetimiba/simvastatina and fibrates has not been studied.
Consult your doctor immediately if you experience unexplained muscle pain, tenderness or weakness. This is because, in rare cases, muscle problems can be severe, including muscle failure which can cause kidney damage; and very rarely, deaths have occurred.
The risk of muscle failure is higher with high doses of ezetimiba/simvastatina, especially the 10/80 mg dose. The risk of muscle failure is also higher in certain patients. Inform your doctor in the following situations:
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medications may be necessary to diagnose and treat this problem.
Children and adolescents
Other medications and Ezetimiba/Simvastatina Pharma Combix
Inform your doctor if you are taking, have taken recently or may need to take any other medication with any of the following active ingredients. Taking ezetimiba/simvastatina with any of the following medications may increase the risk of muscle problems (some of these are already included in the section above "Do not take Ezetimiba/Simvastatina Pharma Combix if").
As well as with the medications mentioned above, inform your doctor or pharmacist if you are taking or have taken recently other medications, even those purchased without a prescription. In particular, inform your doctor if you are taking any of the following:
You should also inform any doctor who prescribes a new medication that you are taking ezetimiba/simvastatina.
Taking Ezetimiba/Simvastatina Pharma Combix with food and drinks
Orange juice contains one or more components that alter the metabolism of some medications, including ezetimiba/simvastatina. You should avoid consuming orange juice, as it may increase the risk of muscle problems.
Pregnancy and breastfeeding
Do not take this medication if you are pregnant, trying to become pregnant or think you may be pregnant. If you become pregnant while taking ezetimiba/simvastatina, stop taking it immediately and inform your doctor. Do not take ezetimiba/simvastatina if you are breastfeeding, as it is unknown whether this medication passes into breast milk.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
Ezetimiba/simvastatina is not expected to interfere with your ability to drive or operate machinery. However, some people may experience dizziness after taking ezetimiba/simvastatina.
Ezetimiba/Simvastatina Pharma Combix contains lactose
If your doctor has told you that you have a lactose intolerance, consult with them before taking this medication.
Your doctor will determine the appropriate dose for you, based on your current treatment and your personal risk situation.
The tablets do not have a groove and should not be divided.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Adults: the dose is1 tabletof ezetimiba/simvastatina once a day by mouth.
Use in adolescents(10 to 17 years old): the dose is1 tabletof ezetimiba/simvastatina once a day by mouth (do not exceed a maximum dose of 10 mg/40 mg once a day).
The dose of ezetimiba/simvastatina 10 mg/80 mg is only recommended for adult patients with very high cholesterol levels and a high risk of heart disease problems who have not achieved treatment goals with lower doses.
Take ezetimiba/simvastatina at night. You can take it with or without food.
If your doctor has prescribed ezetimiba/simvastatina along with another cholesterol-lowering medication that contains the active ingredient colestiramine or any other bile acid sequestrant, you should take ezetimiba/simvastatina at least 2 hours before or 4 hours after taking the bile acid sequestrant.
If you take more Ezetimiba/Simvastatina Pharma Combix than you should
If you forgot to take Ezetimiba/Simvastatina Pharma Combix
If you interrupt the treatment with Ezetimiba/Simvastatina Pharma Combix
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them (see section 2. What you need to know before you start taking Ezetimiba/Simvastatina Pharma Combix).
The following side effects were reported to be frequent (can affect up to 1 in 10 people):
The following side effects were reported to be infrequent (can affect up to 1 in 100 people):
Additionally, the following side effects were reported in people taking ezetimiba/simvastatina or medications containing the active ingredients ezetimiba or simvastatina:
With some statins, the following additional adverse events have been reported:
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Consult your doctor immediately if you experience unexplained muscle pain, sensitivity to pressure, or weakness. This is because, in rare cases, muscle problems can be severe, including muscle failure, which can cause kidney damage; and very rarely, deaths have occurred.
Reporting of side effects:
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:
https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy.If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofEzetimiba/Simvastatina Pharma Combix
butylated hydroxyanisole, citric acid, ascorbic acid, anhydrous lactose, croscarmellose sodium,
sodium stearate fumarate, magnesium stearate (E470b).
Appearance of the product and content of the container
Tablets in capsule form, white to off-white in color, with the engraving “14” on one face and smooth on the other.
Ezetimiba/Simvastatina Pharma Combix10 mg/40 mg is presented in PVC/Aclar-Al and OPA/Al/PVC-Al blisters, available in containers of 28 tablets.
Holder of the marketing authorization
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Responsible for manufacturing
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
or
Centre Spécialités Pharmaceutiques
ZAC des Suzots
35 rue de la Chapelle
63450 Saint Amant Tallende
France
or
Pharmex Advanced Laboratories S.L.
Ctra. A-431 Km. 19
14720 Almodóvar del Río (Córdoba)
Spain
Last review date of this leaflet: April 2023
The detailed and updated information of this medicine is available on the website of the Spanish Agency of Medicaments and Health Products (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.